Free Trial Information
BioCentury | Dec 21, 2019
Company News

Management Tracks: Ionis promotes co-founder to CSO; Syros adds Celgene vet Alles to board; plus Encoded, Cygnal, Harvard Medical School, Immunitas and more

...as CFO and Ann Kapoun as SVP of R&D. Rimac was CFO and CBO at Chrono Therapeutics Inc....
Read More
BioCentury | Feb 2, 2018
Company News

Management tracks: Voyager, Chrono

...to executive science advisor. The gene therapy company is seeking a replacement. Drug delivery company Chrono Therapeutics Inc....
Read More
BioCentury | Sep 12, 2016
Financial News

Chrono Therapeutics completes venture financing

Chrono Therapeutics Inc. , Hayward, Calif. Business: Drug delivery, Neurology Date completed: 2016-09-08 Type: Venture financing Raised: $47.6 million Investors: Kaiser Permanente Ventures; Endeavour Vision; Xeraya Capital; Asahi Kasei; Emergent Medical Partners; Hikma Ventures; Cota Capital;...
Read More
BioCentury | Sep 8, 2016
Financial News

Chrono raises $47.6M in series B

...Drug delivery company Chrono Therapeutics Inc. raised $47.6 million in a series B round led by Kaiser Permanente...
Read More
BioCentury | Aug 1, 2016
Company News

Shire, Chronos Therapeutics deal

Chronos acquired three undisclosed preclinical development programs from Shire focused on fatigue in multiple sclerosis, addictive behaviors and post-traumatic stress disorder. Shire received equity in Chronos and is eligible for regulatory and sales milestones, plus...
Read More
BioCentury | Jul 21, 2016
Company News

Chronos, Shire in deal for preclinical CNS programs

Chronos Therapeutics Ltd. (Oxford, U.K.) acquired from Shire plc (LSE:SHP; NASDAQ:SHPG) three preclinical programs focused on fatigue in multiple sclerosis, addictive behaviors and post-traumatic stress disorder. Shire received equity in Chronos, and is eligible for...
Read More
Items per page:
1 - 6 of 6
BioCentury | Dec 21, 2019
Company News

Management Tracks: Ionis promotes co-founder to CSO; Syros adds Celgene vet Alles to board; plus Encoded, Cygnal, Harvard Medical School, Immunitas and more

...as CFO and Ann Kapoun as SVP of R&D. Rimac was CFO and CBO at Chrono Therapeutics Inc....
Read More
BioCentury | Feb 2, 2018
Company News

Management tracks: Voyager, Chrono

...to executive science advisor. The gene therapy company is seeking a replacement. Drug delivery company Chrono Therapeutics Inc....
Read More
BioCentury | Sep 12, 2016
Financial News

Chrono Therapeutics completes venture financing

Chrono Therapeutics Inc. , Hayward, Calif. Business: Drug delivery, Neurology Date completed: 2016-09-08 Type: Venture financing Raised: $47.6 million Investors: Kaiser Permanente Ventures; Endeavour Vision; Xeraya Capital; Asahi Kasei; Emergent Medical Partners; Hikma Ventures; Cota Capital;...
Read More
BioCentury | Sep 8, 2016
Financial News

Chrono raises $47.6M in series B

...Drug delivery company Chrono Therapeutics Inc. raised $47.6 million in a series B round led by Kaiser Permanente...
Read More
BioCentury | Aug 1, 2016
Company News

Shire, Chronos Therapeutics deal

Chronos acquired three undisclosed preclinical development programs from Shire focused on fatigue in multiple sclerosis, addictive behaviors and post-traumatic stress disorder. Shire received equity in Chronos and is eligible for regulatory and sales milestones, plus...
Read More
BioCentury | Jul 21, 2016
Company News

Chronos, Shire in deal for preclinical CNS programs

Chronos Therapeutics Ltd. (Oxford, U.K.) acquired from Shire plc (LSE:SHP; NASDAQ:SHPG) three preclinical programs focused on fatigue in multiple sclerosis, addictive behaviors and post-traumatic stress disorder. Shire received equity in Chronos, and is eligible for...
Read More
Items per page:
1 - 6 of 6